
Global R&D Pipeline
My Favorite
Hot Targets:
ETB
Back
Total number of drugs
25
Phase II and later clinical stages
16%
Involving companies
19
Main therapeutic areas
Cardiovascular Diseases
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
| Drug | Drug Name En | Drug Type | Treatment Field | Mechanism of Action | Originator | Developer | Indication | Highest Development Stage | Highest Development Stage (China) | Approved Countries/Regions | Approved Time | Approved Time (China) | Special Review | ADC Type | ADC Linker | ADC Payload | ADC DAR | Drug Name | Antibody Type | ADC Linking Site | Operation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A-192621 | A-192621 | Small molecule drug | Cardiovascular Diseases | Endothelin receptor type B antagonists | Abbott Laboratories (Philippines), Inc. | Pending | A-192621 | detail > | |||||||||||||
| BQ-788 | BQ-788 | Small molecule drug | Cardiovascular Diseases Neoplasms Skin and Musculoskeletal Diseases | Endothelin receptor type B antagonists | Merck Serono SA | Early Phase 1 | BQ-788 | detail > | |||||||||||||
| IRL-1038 | IRL-1038 | Synthetic peptide | Cardiovascular Diseases | Endothelin receptor type B antagonists | Novartis AG | Discontinued | IRL-1038 | detail > | |||||||||||||
| RES-701-1 | RES-701-1 | Synthetic peptide | Cardiovascular Diseases | Endothelin receptor type B antagonists | Kyowa Hakko Kogyo Co., Ltd. | Discovery | RES-701-1 | detail > | |||||||||||||
| RES-701-2 | RES-701-2 | Small molecule drug | Endothelin receptor type B antagonists | Kyowa Hakko Kogyo Co., Ltd. | Discontinued | RES-701-2 | detail > | ||||||||||||||
| Ro-46-8443 | Ro-46-8443 | Small molecule drug | Cardiovascular Diseases | Endothelin receptor type B antagonists | F. Hoffmann-La Roche Ltd. | Discontinued | Ro-46-8443 | detail > | |||||||||||||
| [125I]BQ-3020 | [125I]BQ-3020 | Synthetic peptide | Endothelin receptor type B antagonists | Banyu Pharmaceutical Co. Ltd. | Pending | [125I]BQ-3020 | detail > | ||||||||||||||
| K-8768 | K-8768 | Small molecule drug | Cardiovascular Diseases | Endothelin receptor type B antagonists | Kowa Co., Ltd. | Pending | K-8768 | detail > | |||||||||||||
| RG-7636 | RG-7636 | Antibody drug conjugate (ADC) ADC | Neoplasms Skin and Musculoskeletal Diseases | Endothelin receptor type B antagonists Tubulin inhibitors | Genentech, Inc. | Phase 1 | Protease cleavable linker 酶裂解 | MMAE 甲基澳瑞他汀E | RG-7636 | detail > | |||||||||||
| K-8794 | K-8794 | Small molecule drug | Cardiovascular Diseases | Endothelin receptor type B antagonists | Kowa Co., Ltd. | Preclinical | K-8794 | detail > |
Total 25 data
1
2
3


